1. Home
  2. FOXO vs VRAX Comparison

FOXO vs VRAX Comparison

Compare FOXO & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOXO
  • VRAX
  • Stock Information
  • Founded
  • FOXO 2019
  • VRAX 2013
  • Country
  • FOXO United States
  • VRAX United Kingdom
  • Employees
  • FOXO N/A
  • VRAX N/A
  • Industry
  • FOXO Retail: Computer Software & Peripheral Equipment
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • FOXO Technology
  • VRAX Health Care
  • Exchange
  • FOXO Nasdaq
  • VRAX Nasdaq
  • Market Cap
  • FOXO 4.9M
  • VRAX 7.3M
  • IPO Year
  • FOXO N/A
  • VRAX 2022
  • Fundamental
  • Price
  • FOXO $0.21
  • VRAX $2.04
  • Analyst Decision
  • FOXO
  • VRAX
  • Analyst Count
  • FOXO 0
  • VRAX 0
  • Target Price
  • FOXO N/A
  • VRAX N/A
  • AVG Volume (30 Days)
  • FOXO 13.5M
  • VRAX 291.7K
  • Earning Date
  • FOXO 11-19-2024
  • VRAX 02-05-2025
  • Dividend Yield
  • FOXO N/A
  • VRAX N/A
  • EPS Growth
  • FOXO N/A
  • VRAX N/A
  • EPS
  • FOXO N/A
  • VRAX N/A
  • Revenue
  • FOXO $1,341,000.00
  • VRAX $84,872.00
  • Revenue This Year
  • FOXO N/A
  • VRAX $5,169.18
  • Revenue Next Year
  • FOXO N/A
  • VRAX $66.97
  • P/E Ratio
  • FOXO N/A
  • VRAX N/A
  • Revenue Growth
  • FOXO 196.03
  • VRAX 7.03
  • 52 Week Low
  • FOXO $0.13
  • VRAX $0.60
  • 52 Week High
  • FOXO $1.30
  • VRAX $9.00
  • Technical
  • Relative Strength Index (RSI)
  • FOXO 40.02
  • VRAX 53.40
  • Support Level
  • FOXO $0.22
  • VRAX $1.58
  • Resistance Level
  • FOXO $0.23
  • VRAX $2.29
  • Average True Range (ATR)
  • FOXO 0.02
  • VRAX 0.24
  • MACD
  • FOXO 0.00
  • VRAX 0.00
  • Stochastic Oscillator
  • FOXO 13.74
  • VRAX 66.22

About FOXO FOXO Technologies Inc.

FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

Share on Social Networks: